Cytokinetic First Quarter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cytokinetic first quarter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cytokinetic First Quarter Today - Breaking & Trending Today

Cytokinetics Inc (CYTK) Q1 2021 Earnings Call Transcript


Operator
Good afternoon, and welcome, ladies and gentlemen, to Cytokinetics First Quarter 2021 Conference Call. At this time, I would like to inform you that this call is being recorded and that all participants are in a listen-only mode. At the company s request, we will open the call for questions-and-answers after the presentation.
I will now like to turn the call over to Diane Weiser, Cytokinetics Senior Vice President of Corporate Communications and Investor Relations. Please go ahead.
Diane Weiser
Senior Vice President of Corporate Communications & Investor Relations
Good afternoon, and thanks for joining us on the call today. Robert Blum, our President and Chief Executive Officer, will kick off the call with an overview of the quarter and recent developments. Then Fady Malik, our EVP of Research and Development, will provide an update on omecamtiv mecarbil, including progress following a recent meeting with FDA and what to expect from upcoming analys ....

United States , Ji Xing , Morgan Stanley , Salim Syed Mizuho , Stuart Kupfer , Robert Wong , Charles Duncan , Charles Duncan Cantor Fitzgerald , Ted Tentoff , Fady Malik , Andrew Callos , Ted Tentoff Piper Sandler , John Teerlink , Salim Syed , Piper Sandler , Diane Weiser , Robert Blum , Emanuela Branchetti , American Chemical Society Spring , Cytokinetics Inc , Wyeth Pharmaceuticals , American College Of Cardiology , Ji Xing Pharmaceuticals , Corporate Communications Investor Relations , American Chemical Society Annual Meeting , Cantor Fitzgerald ,